Search

You searched for "simulator"

1305 results found

The Case of Dr Bawa-Garba – Do we truly have a ‘no blame’ culture?

1 October 2018 | | EYE - General
Eye News’ medico-legal specialist shares his thoughts on the recent acquittal of Dr Bawa-Garba. On 13 August 2018 the Court of Appeal ruled that Dr Hadiza Bawa-Garba should be reinstated on the UK medical register. The Court of Appeal rejected...

Exeter clinic manager wins VCHP Volunteer Award

10 October 2023 | VCHP, Volunteering, awards, Ben Miles, Zoe Haigh, Exeter
Exeter VCHP clinic manager, Zoe Haigh, has been recognised for her outstanding contribution to the charity during the past six years.

Optical Suppliers Association: Autumn Meeting set for 27 October

22 September 2025 | conference preview, events, meeting, optician, optometry
The OSA’s Autumn Meeting will take place on 27 October at the St Pancras Hotel in London, providing member companies with the chance to learn more about organising their own CPD sessions. Looking ahead to 100% Optical and other opportunities...
Current Eye Research journal cover image.

The effect of everolimus on retinal pigment epithelium and proliferative vitreo-retinopathy

1 August 2018 | | EYE - Vitreo-Retinal
The principal cells involved in proliferative vitreo-retinopathy (PVR) are retinal pigment epithelial cells (RPE). Everolimus is a drug used in renal cell carcinoma which targets and inhibits a key regulatory protein in cancer (mTOR). In this study, the authors investigated...
Progress in Retinal and Eye Research.

How the thinking machine is transforming the retinal landscape

1 May 2025 | | EYE - Vitreo-Retinal
Regulatory approval of the first two therapeutic substances for the management of geographic atrophy (GA) secondary to age-related macular degeneration has been a major breakthrough. The authors explored the issue surrounding the lack of agreed therapeutic standards and diagnostic tools...

3rd Annual Retinal Imaging Biomarkers & Endpoints Summit

27 May 2025 -29 May 2025
Accelerate Your Ophthalmic Development with Deep Learning Systems & Sophisticated AI Imaging TechnologiesWith state-of-the-art AI-assisted technology making retinal imaging 100 times faster, the rapid advancement of technology in ophthalmology, coupled with the strong unmet need for more drugs for retinal...

Celebrate good times, come on!

5 August 2026 |
There seems to be an ever-expanding list of national and international days to celebrate some cause or event, however well-meaning or esoteric. The UN currently marks 218 international days to raise awareness on important issues. Many contorted versions exist, like...

Looking on the brightside: Lord David Blunkett

4 December 2025 | | EYE - General
“I can hear people smile” As a young adult in the 1980s and 1990s I gradually became more politically informed with occasional forays into BBC’s Question Time. In doing so, I learnt of the rise of politician David Blunkett, a...

Protecting and recovering from email hacking

1 February 2016 |
Over the last 12 months I have received emails from more than 20 friends and acquaintances (mostly doctors) who didn’t send those emails. More often than not I find the emails in my ‘Spam’ folder as Gmail knows they are...

Ciliatech presents preliminary results on treating glaucoma with CID at Ophthalmology Futures Symposium

18 September 2023 | Glaucoma, CID, Ciliatech, Research
Ciliatech presents preliminary one-year study results on treating open- and narrow-angle glaucoma with CID at Ophthalmology Futures Symposium.

Myasthenia gravis presenting with isolated ptosis: a poorly studied subgroup

1 February 2015 | | EYE - Vitreo-Retinal
Investigation into the cause of one isolated symptom or sign can be challenging if that particular sign may be caused by a variety of pathological processes, affecting different tissues, and presenting to different specialties. Unilateral ptosis is a case in...

Shifting the paradigm of managing patients in medical retina: how real-world data can help us to improve clinical practice

1 February 2015 | | EYE - Vitreo-Retinal
The ophthalmic subspecialty of ‘medical retina’ has undergone dramatic changes in recent years. With the introduction of ranibizumab (Lucentis, Novartis), a specialty formerly dominated by laser-based therapies has been transformed to become, in large part, pharmacotherapy-based. To date, these pharmacotherapies...